ACHIEVING ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE C-REACTIVE PROTEIN MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH-RELATED QUALITY OF LIFE: 2-YEAR RESULTS FROM GO-RAISE

Author(s):
Heijde, D. van der; Deodhar, A.; Braun, J.; Mack, M.; Hsu, B.; Gathany, T.; Han, C.L.; Inman, R.D.
Published
2013
Publication type
Article / Letter to editor
Date issued
2013-04-30
Language
English
Is part of
Rheumatology (2013), Vol. 52, p. 161-162
hdl
1887/98568